Despite aggressive multimodal therapy and advances in imaging, surgical and radiation techniques, high-grade gliomas remain incurable, with patient
survival often measured in months. Treatment failure is largely attributable to the invasive nature of glioma cells, ineffective delivery of chemotherapeutic
agents across the blood-brain barrier, and dose-limiting systemic toxicities. Neural stem cells (NSCs) have inherent tumor-tropic properties that can be
exploited for targeted delivery of anti-cancer agents. However, current intracranial and intravenous injection approaches for administering NSCs are
not optimal, especially for repeat administrations, because the methods are invasive and may lead to complications.
View Full Article: HERE
Go through the Article: http://www.enlivenarchive.org/stem-cell-research-regenerative-medicine
Contact Us: stemcell-research@enlivenarchive.org
